Name
fibrillin 2
MGI ID
MGI:95490
Synonyms
sy
Sne
Fib-2
Viability
Embryo viewer
N/A
Significant
Not Significant
Not tested
| Phenotype | System | Allele | Zyg | Sex | Life Stage | P Value |
|---|---|---|---|---|---|---|
| abnormal eye morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 0.00 | ||
| abnormal kidney morphology | Fbn2em1(IMPC)Rbrc | HOM | Late adult | 0.00 | ||
| abnormal clavicle morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| abnormal heart morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 0.00 | ||
| abnormal liver morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 0.00 | ||
| decreased body weight | Fbn2em1(IMPC)Rbrc | HOM | Late adult | 1.46×10-36 | ||
| abnormal rib morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 8.97×10-08 | ||
| abnormal humerus morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| abnormal brain morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 0.00 | ||
| abnormal tibia morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| decreased circulating amylase level | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 3.89×10-05 | ||
| abnormal gait | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 3.38×10-06 | ||
| decreased grip strength | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 1.70×10-31 | ||
| decreased body length | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 8.94×10-10 | ||
| abnormal joint morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 9.27×10-07 | ||
| abnormal bone structure | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 4.97×10-06 | ||
| abnormal autopod morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 3.54×10-15 | ||
| abnormal nail morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 3.42×10-15 | ||
| abnormal zygomatic bone morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| abnormal radius morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 4.18×10-10 | ||
| increased liver weight | Fbn2em1(IMPC)Rbrc | HOM | Late adult | 1.58×10-05 | ||
| syndactyly | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| enlarged heart | Fbn2em1(IMPC)Rbrc | HOM | Late adult | 0.00 | ||
| decreased body weight | Fbn2em1(IMPC)Rbrc | HOM | Middle aged adult | 1.44×10-42 | ||
| increased circulating alkaline phosphatase level | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 5.73×10-07 | ||
| increased bone mineral content | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 2.52×10-08 | ||
| abnormal skin morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 3.38×10-06 | ||
| improved glucose tolerance | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.13×10-05 | ||
| abnormal ulna morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| abnormal pelvic girdle bone morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 4.59×10-06 | ||
| abnormal heart morphology | Fbn2em1(IMPC)Rbrc | HOM | Late adult | 0.00 | ||
| abnormal kidney morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 0.00 | ||
| abnormal cranium morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 4.18×10-10 | ||
| abnormal brain morphology | Fbn2em1(IMPC)Rbrc | HOM | Late adult | 0.00 | ||
| vertebral fusion | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 5.16×10-06 | ||
| abnormal liver morphology | Fbn2em1(IMPC)Rbrc | HOM | Late adult | 0.00 | ||
| enlarged heart | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 0.00 | ||
| abnormal tail morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 2.09×10-06 | ||
| decreased total body fat amount | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 2.53×10-08 | ||
| abnormal mandible morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| abnormal femur morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| abnormal vertebral arch morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 | ||
| abnormal digit morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 1.21×10-21 | ||
| abnormal fibula morphology | Fbn2em1(IMPC)Rbrc | HOM | Early adult | 6.97×10-11 |
Select physiological systems to view:
Viewing: all phenotypes
Select physiological systems to view:
Viewing: all phenotypes
